Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

1.

Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study.

Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, Rasmussen SA, Jenike MA.

Am J Psychiatry. 2002 Feb;159(2):263-8.

PMID:
11823269
[PubMed - indexed for MEDLINE]
2.

Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder.

Rufer M, Grothusen A, Mass R, Peter H, Hand I.

J Affect Disord. 2005 Sep;88(1):99-102.

PMID:
16040125
[PubMed - indexed for MEDLINE]
3.

Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.

Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L.

Am J Psychiatry. 1999 Sep;156(9):1409-16.

PMID:
10484953
[PubMed - indexed for MEDLINE]
4.

Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up.

Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Räuchle H, Hohagen F.

Eur Arch Psychiatry Clin Neurosci. 2005 Feb;255(1):48-50. Epub 2004 Nov 12.

PMID:
15538591
[PubMed - indexed for MEDLINE]
5.

Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.

Catapano F, Perris F, Masella M, Rossano F, Cigliano M, Magliano L, Maj M.

J Psychiatr Res. 2006 Sep;40(6):502-10.

PMID:
16904424
[PubMed - indexed for MEDLINE]
6.

Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, Vallejo J.

J Clin Psychiatry. 2001 Jul;62(7):535-40.

PMID:
11488364
[PubMed - indexed for MEDLINE]
7.

Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.

Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, Fricke S, Peter H.

Eur Arch Psychiatry Clin Neurosci. 2005 Apr;255(2):121-8. Epub 2004 Nov 12.

PMID:
15812606
[PubMed - indexed for MEDLINE]
8.

Symptom structure in Japanese patients with obsessive-compulsive disorder.

Matsunaga H, Maebayashi K, Hayashida K, Okino K, Matsui T, Iketani T, Kiriike N, Stein DJ.

Am J Psychiatry. 2008 Feb;165(2):251-3. Epub 2007 Nov 15. Erratum in: Am J Psychiatry. 2008 Feb;165(2):266.

PMID:
18006873
[PubMed - indexed for MEDLINE]
9.

Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.

Stein DJ, Andersen EW, Overo KF.

Rev Bras Psiquiatr. 2007 Dec;29(4):303-7.

PMID:
18200396
[PubMed - indexed for MEDLINE]
Free Article
10.

Longitudinal assessment of symptom and subtype categories in obsessive-compulsive disorder.

Besiroglu L, Uguz F, Ozbebit O, Guler O, Cilli AS, Askin R.

Depress Anxiety. 2007;24(7):461-6.

PMID:
17131352
[PubMed - indexed for MEDLINE]
11.

Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.

van Oppen P, van Balkom AJ, de Haan E, van Dyck R.

J Clin Psychiatry. 2005 Nov;66(11):1415-22.

PMID:
16420079
[PubMed - indexed for MEDLINE]
12.

Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

Tundo A, Salvati L, Busto G, Di Spigno D, Falcini R.

J Clin Psychiatry. 2007 Oct;68(10):1552-6.

PMID:
17960971
[PubMed - indexed for MEDLINE]
13.

Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial.

Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L.

Psychother Psychosom. 2002 Sep-Oct;71(5):255-62.

PMID:
12207105
[PubMed - indexed for MEDLINE]
14.

A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

Leonard HL, Swedo SE, Lenane MC, Rettew DC, Hamburger SD, Bartko JJ, Rapoport JL.

Arch Gen Psychiatry. 1993 Jun;50(6):429-39.

PMID:
8498877
[PubMed - indexed for MEDLINE]
15.

Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.

Alonso P, Menchón JM, Mataix-Cols D, Pifarré J, Urretavizcaya M, Crespo JM, Jiménez S, Vallejo G, Vallejo J.

Psychiatry Res. 2004 Jul 15;127(3):267-78.

PMID:
15296826
[PubMed - indexed for MEDLINE]
16.

Treatment of obsessive-compulsive disorder: personal follow-up of a 10-year material from an outpatient county clinic.

Olsen T, Mais AH, Bilet T, Martinsen EW.

Nord J Psychiatry. 2008;62(1):39-45. doi: 10.1080/08039480801960230.

PMID:
18389424
[PubMed - indexed for MEDLINE]
17.

Obsessive-compulsive disorder with poor insight: a three-year prospective study.

Catapano F, Perris F, Fabrazzo M, Cioffi V, Giacco D, De Santis V, Maj M.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):323-30. doi: 10.1016/j.pnpbp.2009.12.007. Epub 2009 Dec 16.

PMID:
20015461
[PubMed - indexed for MEDLINE]
18.

Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome.

Rufer M, Fricke S, Moritz S, Kloss M, Hand I.

Acta Psychiatr Scand. 2006 May;113(5):440-6.

PMID:
16603035
[PubMed - indexed for MEDLINE]
19.

Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases.

Thomsen PH, Mikkelsen HU.

J Am Acad Child Adolesc Psychiatry. 1995 Nov;34(11):1432-40.

PMID:
8543510
[PubMed - indexed for MEDLINE]
20.

A prospective long-term follow-up study of alexithymia in obsessive-compulsive disorder.

Rufer M, Ziegler A, Alsleben H, Fricke S, Ortmann J, Brückner E, Hand I, Peter H.

Compr Psychiatry. 2006 Sep-Oct;47(5):394-8. Epub 2006 Apr 19.

PMID:
16905403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk